These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 25851569)

  • 1. The Use of Induced Pluripotent Stem Cell Technology to Advance Autism Research and Treatment.
    Acab A; Muotri AR
    Neurotherapeutics; 2015 Jul; 12(3):534-45. PubMed ID: 25851569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling the Interplay Between Neurons and Astrocytes in Autism Using Human Induced Pluripotent Stem Cells.
    Russo FB; Freitas BC; Pignatari GC; Fernandes IR; Sebat J; Muotri AR; Beltrão-Braga PCB
    Biol Psychiatry; 2018 Apr; 83(7):569-578. PubMed ID: 29129319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human Inducible Pluripotent Stem Cells and Autism Spectrum Disorder: Emerging Technologies.
    Nestor MW; Phillips AW; Artimovich E; Nestor JE; Hussman JP; Blatt GJ
    Autism Res; 2016 May; 9(5):513-35. PubMed ID: 26426199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding the molecular basis of autism in a dish using hiPSCs-derived neurons from ASD patients.
    Lim CS; Yang JE; Lee YK; Lee K; Lee JA; Kaang BK
    Mol Brain; 2015 Sep; 8(1):57. PubMed ID: 26419846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modeling the autistic cell: iPSCs recapitulate developmental principles of syndromic and nonsyndromic ASD.
    Ben-Reuven L; Reiner O
    Dev Growth Differ; 2016 Jun; 58(5):481-91. PubMed ID: 27111774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modeling autism spectrum disorders with human neurons.
    Beltrão-Braga PC; Muotri AR
    Brain Res; 2017 Feb; 1656():49-54. PubMed ID: 26854137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induced pluripotent stem cells as a tool to study brain circuits in autism-related disorders.
    Vitrac A; Cloëz-Tayarani I
    Stem Cell Res Ther; 2018 Aug; 9(1):226. PubMed ID: 30139379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Autism Spectrum Disorders Stem Cell Resource at Children's Hospital of Orange County: Implications for Disease Modeling and Drug Discovery.
    Brick DJ; Nethercott HE; Montesano S; Banuelos MG; Stover AE; Schutte SS; O'Dowd DK; Hagerman RJ; Ono M; Hessl DR; Tassone F; Schwartz PH
    Stem Cells Transl Med; 2014 Nov; 3(11):1275-86. PubMed ID: 25273538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of iPSC technology for modeling Autism Spectrum Disorders.
    Russo FB; Brito A; de Freitas AM; Castanha A; de Freitas BC; Beltrão-Braga PCB
    Neurobiol Dis; 2019 Oct; 130():104483. PubMed ID: 31129084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Personalized genome sequencing coupled with iPSC technology identifies GTDC1 as a gene involved in neurodevelopmental disorders.
    Aksoy I; Utami KH; Winata CL; Hillmer AM; Rouam SL; Briault S; Davila S; Stanton LW; Cacheux V
    Hum Mol Genet; 2017 Jan; 26(2):367-382. PubMed ID: 28365779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring the mechanisms underlying excitation/inhibition imbalance in human iPSC-derived models of ASD.
    Culotta L; Penzes P
    Mol Autism; 2020 May; 11(1):32. PubMed ID: 32393347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of an induced pluripotent stem cell line from a patient with autism spectrum disorder and SCN2A haploinsufficiency.
    Sampaio GLA; Martins GLS; Paredes BD; Nonaka CKV; da Silva KN; Rossi EA; Dos Santos RR; Soares MBP; Souza BSF
    Stem Cell Res; 2019 Aug; 39():101488. PubMed ID: 31272037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysregulation of Neurite Outgrowth and Cell Migration in Autism and Other Neurodevelopmental Disorders.
    Prem S; Millonig JH; DiCicco-Bloom E
    Adv Neurobiol; 2020; 25():109-153. PubMed ID: 32578146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mind the translational gap: using iPS cell models to bridge from genetic discoveries to perturbed pathways and therapeutic targets.
    Pintacuda G; Martín JM; Eggan KC
    Mol Autism; 2021 Feb; 12(1):10. PubMed ID: 33557935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement C4 Is Reduced in iPSC-Derived Astrocytes of Autism Spectrum Disorder Subjects.
    Mansur F; Teles E Silva AL; Gomes AKS; Magdalon J; de Souza JS; Griesi-Oliveira K; Passos-Bueno MR; Sertié AL
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro models for ASD-patient-derived iPSCs and cerebral organoids.
    Hohmann SS; Ilieva M; Michel TM
    Prog Mol Biol Transl Sci; 2020; 173():355-375. PubMed ID: 32711817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rare RELN variants affect Reelin-DAB1 signal transduction in autism spectrum disorder.
    Sánchez-Sánchez SM; Magdalon J; Griesi-Oliveira K; Yamamoto GL; Santacruz-Perez C; Fogo M; Passos-Bueno MR; Sertié AL
    Hum Mutat; 2018 Oct; 39(10):1372-1383. PubMed ID: 29969175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modeling neurodevelopmental disorders using human neurons.
    Chailangkarn T; Acab A; Muotri AR
    Curr Opin Neurobiol; 2012 Oct; 22(5):785-90. PubMed ID: 22717528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NRXN1α
    Avazzadeh S; Quinlan LR; Reilly J; McDonagh K; Jalali A; Wang Y; McInerney V; Krawczyk J; Ding Y; Fitzgerald J; O'Sullivan M; Forman EB; Lynch SA; Ennis S; Feerick N; Reilly R; Li W; Shen X; Yang G; Lu Y; Peeters H; Dockery P; O'Brien T; Shen S; Gallagher L
    BMC Neurosci; 2021 Sep; 22(1):56. PubMed ID: 34525970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human stem cell-based models for studying autism spectrum disorder-related neuronal dysfunction.
    Cheffer A; Flitsch LJ; Krutenko T; Röderer P; Sokhranyaeva L; Iefremova V; Hajo M; Peitz M; Schwarz MK; Brüstle O
    Mol Autism; 2020 Dec; 11(1):99. PubMed ID: 33308283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.